Product
SB204
Aliases
NVN1000, SB204 4%
4 clinical trials
1 indication
Indication
Acne VulgarisClinical trial
A Phase 3 Multi-Center, Open Label Study Evaluating the Long Term Safety of SB204 Once Daily in the Treatment of Acne VulgarisStatus: Completed, Estimated PCD: 2017-04-01
Clinical trial
A Phase 3 Multi-Center, Randomized, Double-Blinded, Vehicle-Controlled, Parallel Group Study Comparing the Efficacy, Tolerability and Safety of SB204 and Vehicle Gel Once Daily in the Treatment of Acne VulgarisStatus: Completed, Estimated PCD: 2016-12-01
Clinical trial
A Phase 3 Multi-Center, Randomized, Double-Blinded, Vehicle-Controlled, Parallel Group Study Comparing the Efficacy, Tolerability and Safety of Once Daily SB204 and Vehicle Gel in the Treatment of Acne VulgarisStatus: Completed, Estimated PCD: 2016-12-01
Clinical trial
A Phase 2, Multi-Center, Randomized, Evaluator-Blinded, Vehicle-Controlled Study Comparing the Efficacy, Tolerability, and Safety of SB204 Gel and Vehicle Gel Once or Twice Daily in the Treatment of Acne VulgarisStatus: Completed, Estimated PCD: 2015-06-01